FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2087492799> ?p ?o ?g. }

• W2087492799 abstract "Carcinoembryonic antigen (CEA; CD66e, CEACAM5) is a well-characterized tumor-associated antigen that is frequently and uniformly over-expressed in human carcinomas. A novel bispecific single-chain antibody of the bispecific T cell engager (BiTE) class named MEDI-565 (also known as MT111) was generated by genetic engineering. MEDI-565 binds CEA on cancer cells and CD3 present on T cells; such binding mediates T cell killing of cancer cells expressing CEA. However, MEDI-565 effectively mediates the killing of cancer cells only if it binds concurrently to CEA on a cancer cell and to CD3 on a T cell. We hypothesized that metastatic human colorectal cancer (CRC) previously treated with conventional chemotherapy would be sensitive to T cell-mediated killing if T cells of a sufficient magnitude could be activated against the tumor. To test this hypothesis, we selected MEDI-565 to redirect a large number of polyclonal T cells against tumors expressing CEA instead of using a cancer vaccine approach that, in general, is anticipated to elicit few antigen-specific T cells in humans. We analyzed proliferation and lysis of CEA-positive CRC specimens that had survived prior systemic chemotherapy and biologic therapy to determine if they could be killed by patient T cells engaged by MEDI-565 in vitro. The mechanism of redirected T cell killing was also investigated. At low concentrations (0.1 to 1 ng/mL), MEDI-565 plus T cells caused reduced proliferation and enhanced apoptosis of CEA-positive human CRC specimens. High levels of soluble CEA (≤ 1,000 ng/mL) did not affect MEDI-565-induced T cell killing of cells expressing CEA, suggesting that endogenous circulating CEA may not impair the clinical activity of MEDI-565 in patients. Cancer cell lines expressing CEA remained sensitive to T cell mediated killing despite repeated exposure to T cells and MEDI-565. These results suggest that MEDI-565/T-cell treatment may not induce escape mechanisms in cancer cells, and, thus, might be suitable for long-term and repeated treatment. Granzyme B and perforin were implicated as potential mediators of MEDI-565-induced T cell killing. Furthermore, MEDI-565 activated T cells to secrete both Tc1 (Th1) and Tc2 (Th2) type cytokines. This study demonstrates for the first time that metastatic CRC specimens derived from patients previously treated with conventional chemotherapy can be lysed by patient T cells. Clinical testing of cancer immunotherapies such as MEDI-565 that result in exposure of tumors to large numbers of T cells is warranted. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 5338." @default.
• W2087492799 created "2016-06-24" @default.
• W2087492799 creator A5012804507 @default.
• W2087492799 creator A5023821870 @default.
• W2087492799 creator A5028156079 @default.
• W2087492799 creator A5045134210 @default.
• W2087492799 creator A5074731037 @default.
• W2087492799 creator A5077597600 @default.
• W2087492799 creator A5078319562 @default.
• W2087492799 creator A5089632095 @default.
• W2087492799 date "2010-04-15" @default.
• W2087492799 modified "2023-09-27" @default.
• W2087492799 title "Abstract 5338: Metastatic colorectal cancer cells from patients previously treated with chemotherapy are sensitive to T cell killing mediated by CEA/CD3-bispecific T cell-engaging BiTE antibody" @default.
• W2087492799 doi "https://doi.org/10.1158/1538-7445.am10-5338" @default.
• W2087492799 hasPublicationYear "2010" @default.
• W2087492799 type Work @default.
• W2087492799 sameAs 2087492799 @default.
• W2087492799 citedByCount "0" @default.
• W2087492799 crossrefType "proceedings-article" @default.
• W2087492799 hasAuthorship W2087492799A5012804507 @default.
• W2087492799 hasAuthorship W2087492799A5023821870 @default.
• W2087492799 hasAuthorship W2087492799A5028156079 @default.
• W2087492799 hasAuthorship W2087492799A5045134210 @default.
• W2087492799 hasAuthorship W2087492799A5074731037 @default.
• W2087492799 hasAuthorship W2087492799A5077597600 @default.
• W2087492799 hasAuthorship W2087492799A5078319562 @default.
• W2087492799 hasAuthorship W2087492799A5089632095 @default.
• W2087492799 hasConcept C114684123 @default.
• W2087492799 hasConcept C121608353 @default.
• W2087492799 hasConcept C126322002 @default.
• W2087492799 hasConcept C147483822 @default.
• W2087492799 hasConcept C159654299 @default.
• W2087492799 hasConcept C167672396 @default.
• W2087492799 hasConcept C203014093 @default.
• W2087492799 hasConcept C2776090121 @default.
• W2087492799 hasConcept C2776694085 @default.
• W2087492799 hasConcept C2777387746 @default.
• W2087492799 hasConcept C502942594 @default.
• W2087492799 hasConcept C526805850 @default.
• W2087492799 hasConcept C71924100 @default.
• W2087492799 hasConcept C8891405 @default.
• W2087492799 hasConcept C96232424 @default.
• W2087492799 hasConceptScore W2087492799C114684123 @default.
• W2087492799 hasConceptScore W2087492799C121608353 @default.
• W2087492799 hasConceptScore W2087492799C126322002 @default.
• W2087492799 hasConceptScore W2087492799C147483822 @default.
• W2087492799 hasConceptScore W2087492799C159654299 @default.
• W2087492799 hasConceptScore W2087492799C167672396 @default.
• W2087492799 hasConceptScore W2087492799C203014093 @default.
• W2087492799 hasConceptScore W2087492799C2776090121 @default.
• W2087492799 hasConceptScore W2087492799C2776694085 @default.
• W2087492799 hasConceptScore W2087492799C2777387746 @default.
• W2087492799 hasConceptScore W2087492799C502942594 @default.
• W2087492799 hasConceptScore W2087492799C526805850 @default.
• W2087492799 hasConceptScore W2087492799C71924100 @default.
• W2087492799 hasConceptScore W2087492799C8891405 @default.
• W2087492799 hasConceptScore W2087492799C96232424 @default.
• W2087492799 hasLocation W20874927991 @default.
• W2087492799 hasOpenAccess W2087492799 @default.
• W2087492799 hasPrimaryLocation W20874927991 @default.
• W2087492799 hasRelatedWork W1608904669 @default.
• W2087492799 hasRelatedWork W1972730017 @default.
• W2087492799 hasRelatedWork W1978477412 @default.
• W2087492799 hasRelatedWork W1987649909 @default.
• W2087492799 hasRelatedWork W1999815959 @default.
• W2087492799 hasRelatedWork W2006613911 @default.
• W2087492799 hasRelatedWork W2013226620 @default.
• W2087492799 hasRelatedWork W2037934166 @default.
• W2087492799 hasRelatedWork W2064804816 @default.
• W2087492799 hasRelatedWork W2076844516 @default.
• W2087492799 hasRelatedWork W2337778663 @default.
• W2087492799 hasRelatedWork W2345731019 @default.
• W2087492799 hasRelatedWork W2742131221 @default.
• W2087492799 hasRelatedWork W2807432296 @default.
• W2087492799 hasRelatedWork W2887898700 @default.
• W2087492799 hasRelatedWork W2954358786 @default.
• W2087492799 hasRelatedWork W2955393953 @default.
• W2087492799 hasRelatedWork W2969279501 @default.
• W2087492799 hasRelatedWork W2980131820 @default.
• W2087492799 hasRelatedWork W3033942733 @default.
• W2087492799 isParatext "false" @default.
• W2087492799 isRetracted "false" @default.
• W2087492799 magId "2087492799" @default.
• W2087492799 workType "article" @default.